{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:37:52Z","timestamp":1789605472580,"version":"build-2803163510"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","award":["ZNJC202330"],"award-info":[{"award-number":["ZNJC202330"]}],"id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB742"],"award-info":[{"award-number":["2023AFB742"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373411"],"award-info":[{"award-number":["82373411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.semcancer.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T16:02:49Z","timestamp":1753286569000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Host-microbiota interactions in genitourinary cancer immunotherapy"],"prefix":"10.1016","volume":"115","author":[{"given":"Xiao-Feng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Long","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-725X","authenticated-orcid":false,"given":"Xian-Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib2","first-page":"64","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1186\/s12889-024-18353-9","article-title":"Changes in disease burden and global inequalities in bladder, kidney and prostate cancers from 1990 to 2019: a comparative analysis based on the global burden of disease study 2019","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1186\/s12885-022-10244-9","article-title":"Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib5","first-page":"60","article-title":"Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019","volume":"8","author":"Zi","year":"2021","journal-title":"Mil. Med. Res."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/iju.15278","article-title":"Recent advances in immune checkpoint inhibitors in the treatment of urothelial carcinoma: a review","volume":"30","author":"Kato","year":"2023","journal-title":"Int. J. Urol."},{"issue":"9","key":"10.1016\/j.semcancer.2025.07.005_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092187","article-title":"Immune checkpoint inhibitors in prostate cancer","volume":"13","author":"Venkatachalam","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.semcancer.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s43018-024-00820-2","article-title":"Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers","volume":"5","author":"Dong","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.semcancer.2025.07.005_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190850","article-title":"An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001198","article-title":"Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma","volume":"8","author":"Patel","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0111","article-title":"The gut microbiome: a core regulator of metabolism","volume":"256","author":"Fujisaka","year":"2023","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.semcancer.2025.07.005_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429436","article-title":"Microbiota activation and regulation of adaptive immunity","volume":"15","author":"Heidari","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11051207","article-title":"Current viewpoint on female urogenital microbiome-the cause or the consequence?","volume":"11","author":"Ceprnja","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.semcancer.2025.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.617002","article-title":"Urinary microbiome: Yin and Yang of the urinary tract","volume":"11","author":"Perez-Carrasco","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.805459","article-title":"Prostate microbiota and prostate cancer: a new trend in treatment","volume":"11","author":"Che","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.100638","article-title":"Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management","volume":"47","author":"Lee","year":"2024","journal-title":"Biomed. J."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.kint.2020.04.048","article-title":"Intestinal microbiota control acute kidney injury severity by immune modulation","volume":"98","author":"Yang","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.semcancer.2025.07.005_bib19","article-title":"Research progress of bile acids in cancer","volume":"11","author":"Fu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70023","article-title":"Cutting-edge advancements in the antibiotics-gut microbiota-urinary tumour axis","author":"Wang","year":"2025","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2024.10.014","article-title":"Causal relationship between bladder cancer and gut microbiota contributes to the gut-bladder axis: a two-sample Mendelian randomization study","volume":"43","author":"Yang","year":"2025","journal-title":"Urol. Oncol."},{"issue":"1-2","key":"10.1016\/j.semcancer.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10555-018-09775-0","article-title":"Cancer-associated mucins: role in immune modulation and metastasis","volume":"38","author":"Bhatia","year":"2019","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.urology.2005.07.048","article-title":"Enhanced binding of modified pentosan polysulfate and heparin to bladder--a strategy for improved treatment of interstitial cystitis","volume":"67","author":"Muthusamy","year":"2006","journal-title":"Urology"},{"issue":"24","key":"10.1016\/j.semcancer.2025.07.005_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413642","article-title":"Mucins Dynamics in physiological and pathological conditions","volume":"22","author":"Melhem","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"F305","DOI":"10.1152\/ajprenal.00341.2003","article-title":"Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium","volume":"287","author":"Acharya","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"10.1016\/j.semcancer.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1128\/IAI.73.11.7644-7656.2005","article-title":"Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract","volume":"73","author":"Lane","year":"2005","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00246-24","article-title":"Mucin alleviates colonic barrier dysfunction by promoting spermine accumulation through enhanced arginine metabolism in Limosilactobacillus mucosae","volume":"9","author":"Zhou","year":"2024","journal-title":"mSystems"},{"key":"10.1016\/j.semcancer.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mib.2021.09.014","article-title":"Colonization resistance: metabolic warfare as a strategy against pathogenic Enterobacteriaceae","volume":"64","author":"Shealy","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"issue":"9","key":"10.1016\/j.semcancer.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.3168\/jds.2016-11166","article-title":"Purification and characterization of a novel bacteriocin produced by Lactobacillus crustorum MN047 isolated from koumiss from Xinjiang, China","volume":"99","author":"Yi","year":"2016","journal-title":"J. Dairy Sci."},{"issue":"1946","key":"10.1016\/j.semcancer.2025.07.005_bib30","article-title":"Nutrient conditions are primary drivers of bacterial capsule maintenance in Klebsiella","volume":"288","author":"Buffet","year":"2021","journal-title":"Proc. Biol. Sci."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41579-022-00833-7","article-title":"Microbiota-mediated colonization resistance: mechanisms and regulation","volume":"21","author":"Caballero-Flores","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib32","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.4049\/jimmunol.163.12.6718","article-title":"Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium","volume":"163","author":"O'Neil","year":"1999","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ki.2011.109","article-title":"Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract","volume":"80","author":"Spencer","year":"2011","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib34","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/s12276-023-01054-5","article-title":"Reg3gamma: current understanding and future therapeutic opportunities in metabolic disease","volume":"55","author":"Shin","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1172\/JCI1861","article-title":"Human beta-defensin-1: an antimicrobial peptide of urogenital tissues","volume":"101","author":"Valore","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365597409132126","article-title":"Lysozyme in seminal fluid of healthy males and patients with prostatitis and in tissues of the male uro-genital tract","volume":"8","author":"Mardh","year":"1974","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1462-5822.2002.00208.x","article-title":"TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14","volume":"4","author":"Backhed","year":"2002","journal-title":"Cell Microbiol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jcp.29976","article-title":"Site-specific contribution of Toll-like receptor 4 to intestinal homeostasis and inflammatory disease","volume":"236","author":"Bruning","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70299","article-title":"The role of cancer-associated fibroblasts in the tumour microenvironment of urinary system","volume":"15","author":"Hong","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.semcancer.2025.07.005_bib42","article-title":"Interferon regulatory factor 5: a potential target for therapeutic intervention in inflammatory diseases","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158200","article-title":"Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?","volume":"14","author":"Dong","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1445-2197.2003.02652.x","article-title":"The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line","volume":"73","author":"Frydoonfar","year":"2003","journal-title":"ANZ J. Surg."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20011983","article-title":"Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes","volume":"195","author":"Yoneyama","year":"2002","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molmed.2023.07.002","article-title":"The global human gut microbiome: genes, lifestyles, and diet","volume":"29","author":"Parizadeh","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","article-title":"Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity","volume":"45","author":"Bemark","year":"2024","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"7837","key":"10.1016\/j.semcancer.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans","volume":"588","author":"Schluter","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib52","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"6145","key":"10.1016\/j.semcancer.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114306","article-title":"Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila","volume":"43","author":"Zhu","year":"2024","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"22","key":"10.1016\/j.semcancer.2025.07.005_bib57","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1158\/0008-5472.CAN-23-0605","article-title":"Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA4 and PD-1 checkpoint blockade","volume":"83","author":"Gao","year":"2023","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib58","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","article-title":"Enterotoxigenic Bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p","volume":"161","author":"Cao","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.chom.2018.01.007","article-title":"Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells","volume":"23","author":"Chung","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2423043","article-title":"KRAS mutations promote the intratumoral colonization of enterotoxigenic Bacteroides fragilis in colorectal cancer through the regulation of the miRNA3655\/SURF6\/IRF7\/IFNbeta axis","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"issue":"Pt 3","key":"10.1016\/j.semcancer.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.semcancer.2021.11.002","article-title":"The oral microbiota and its role in carcinogenesis","volume":"86","author":"Stasiewicz","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib62","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00262-022-03348-5","article-title":"Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment","volume":"72","author":"Guo","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2073785","article-title":"Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils","volume":"14","author":"Tan","year":"2022","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/0022034520909312","article-title":"Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment","volume":"99","author":"Wen","year":"2020","journal-title":"J. Dent. Res"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib65","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2388801","article-title":"Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion","volume":"16","author":"Diaz-Basabe","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/prd.12540","article-title":"Periodontitis and risk of cancer: Mechanistic evidence","volume":"96","author":"Baima","year":"2024","journal-title":"Periodontol 2000"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2458203","article-title":"Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1","volume":"17","author":"Duizer","year":"2025","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2025.07.005_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-025-01174-x","article-title":"Commensalism and pathogenesis of Candida albicans at the mucosal interface","author":"Schille","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"7937","key":"10.1016\/j.semcancer.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Nino","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"issue":"15","key":"10.1016\/j.semcancer.2025.07.005_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu1727","article-title":"Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma","volume":"11","author":"Mou","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","article-title":"Fusobacterium nucleatum - symbiont, opportunist and oncobacterium","volume":"17","author":"Brennan","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib75","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1038\/s41467-023-40987-3","article-title":"Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","article-title":"Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer","volume":"6","author":"Gao","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"37","key":"10.1016\/j.semcancer.2025.07.005_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg5016","article-title":"High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity","volume":"7","author":"Rizvi","year":"2021","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.semcancer.2025.07.005_bib78","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib79","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/gutjnl-2022-327853","article-title":"Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment","volume":"72","author":"Jiang","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2166700","article-title":"Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01993-24","article-title":"Breast cancer colonization by Malassezia globosa accelerates tumor growth","volume":"15","author":"Liu","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","article-title":"Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer","volume":"32","author":"Wang","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2025.07.005_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41585-025-01011-z","article-title":"The role of the urinary microbiome in genitourinary cancers","author":"Lee","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bucevic Popovic","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051423","article-title":"Microbiota of urine, glans and prostate biopsies in patients with prostate cancer reveals a dysbiosis in the genitourinary system","volume":"15","author":"Goncalves","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib86","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1349-7006.2009.01426.x","article-title":"Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors","volume":"101","author":"Seow","year":"2010","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.juro.2017.08.001","article-title":"Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer","volume":"199","author":"Shrestha","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib88","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-immunol-101721-031732","article-title":"Effector-Triggered Immunity","volume":"41","author":"Remick","year":"2023","journal-title":"Annu Rev. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib89","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The 'cytokine storm': molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib90","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","article-title":"Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity","volume":"20","author":"Kim","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761981","article-title":"Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib92","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gutjnl-2022-327952","article-title":"Fungi and cancer","volume":"72","author":"Saftien","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.07.005_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcdb.2018.05.023","article-title":"Fungal mediated innate immune memory, what have we learned?","volume":"89","author":"Quintin","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib94","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/apt.12665","article-title":"Review article: fungal microbiota and digestive diseases","volume":"39","author":"Wang","year":"2014","journal-title":"Aliment Pharm. Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.36","article-title":"Microbiota in T-cell homeostasis and inflammatory diseases","volume":"49","author":"Lee","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","article-title":"Gut microbiota in colorectal cancer development and therapy","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib97","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib98","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib99","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.immuni.2015.01.008","article-title":"Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation","volume":"42","author":"Kashem","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2025.02.005","article-title":"IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis","volume":"58","author":"Denk","year":"2025","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.semcancer.2025.07.005_bib101","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib102","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.immuni.2024.09.011","article-title":"Antigen-presenting cells as specialized drivers of intestinal T cell functions","volume":"57","author":"Kedmi","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.smim.2011.11.004","article-title":"How the interplay between antigen presenting cells and microbiota tunes host immune responses in the gut","volume":"24","author":"Swiatczak","year":"2012","journal-title":"Semin. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109726","article-title":"Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling","volume":"36","author":"Hu","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI124332","article-title":"Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response","volume":"130","author":"Uribe-Herranz","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib106","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/1871520611313050003","article-title":"The effects of beta-glucans on dendritic cells and implications for cancer therapy","volume":"13","author":"Albeituni","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"issue":"48","key":"10.1016\/j.semcancer.2025.07.005_bib107","doi-asserted-by":"crossref","first-page":"26296","DOI":"10.1021\/jacs.3c09472","article-title":"Transforming intratumor bacteria into immunopotentiators to reverse cold tumors for enhanced immuno-chemodynamic therapy of triple-negative breast cancer","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.semcancer.2025.07.005_bib108","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-932-2","article-title":"Targeting macrophages in cancer immunotherapy: Frontiers and challenges","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.semcancer.2025.07.005_bib109","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41418-019-0312-y","article-title":"Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"issue":"31","key":"10.1016\/j.semcancer.2025.07.005_bib110","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/s41388-024-03080-7","article-title":"Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation","volume":"43","author":"Gu","year":"2024","journal-title":"Oncogene"},{"issue":"6285","key":"10.1016\/j.semcancer.2025.07.005_bib111","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.aad9378","article-title":"How colonization by microbiota in early life shapes the immune system","volume":"352","author":"Gensollen","year":"2016","journal-title":"Science"},{"issue":"6391","key":"10.1016\/j.semcancer.2025.07.005_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2025.07.005_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2025.01.011","article-title":"AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity","author":"Wei","year":"2025","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib114","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib116","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.cmet.2024.04.019","article-title":"Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells","volume":"36","author":"Liu","year":"2024","journal-title":"Cell Metab."},{"issue":"20","key":"10.1016\/j.semcancer.2025.07.005_bib117","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306776121","article-title":"A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation","volume":"121","author":"Chen","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib118","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib119","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41564-019-0541-3","article-title":"Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity","volume":"4","author":"Long","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib120","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2348441","article-title":"Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis","volume":"16","author":"Lu","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib121","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2295384","article-title":"Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1\/TIFA axis activation","volume":"16","author":"Martin-Gallausiaux","year":"2024","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib122","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","article-title":"Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system","volume":"41","author":"Ala","year":"2022","journal-title":"Int. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122382","article-title":"Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases","volume":"10","author":"Effendi","year":"2022","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib124","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"issue":"6371","key":"10.1016\/j.semcancer.2025.07.005_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2025.07.005_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100850","article-title":"Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer","volume":"35","author":"Gao","year":"2023","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.semcancer.2025.07.005_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.111168","article-title":"Fusobacterium nucleatum promotes PD-L1 expression in cancer cells to evade CD8(+) T cell killing in breast cancer","volume":"85","author":"Guo","year":"2024","journal-title":"Hum. Immunol."},{"issue":"6264","key":"10.1016\/j.semcancer.2025.07.005_bib128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"issue":"6510","key":"10.1016\/j.semcancer.2025.07.005_bib129","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41568-022-00462-5","article-title":"Context-dependent functions of pattern recognition receptors in cancer","volume":"22","author":"Man","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib131","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib132","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12964-025-02149-4","article-title":"An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein-protein interactions","volume":"23","author":"Luo","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"6832","key":"10.1016\/j.semcancer.2025.07.005_bib133","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","article-title":"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5","volume":"410","author":"Hayashi","year":"2001","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib134","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.apsb.2021.04.019","article-title":"Salmonella flagella confer anti-tumor immunological effect via activating Flagellin\/TLR5 signalling within tumor microenvironment","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.semcancer.2025.07.005_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9068068","article-title":"Microbiome within primary tumor tissue from renal cell carcinoma may be associated with PD-L1 expression of the venous tumor thrombus","volume":"2020","author":"Liss","year":"2020","journal-title":"Adv. Urol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2024.115420","article-title":"Butyrate: a potential mediator of obesity and microbiome via different mechanisms of actions","volume":"199","author":"Saban Guler","year":"2025","journal-title":"Food Res. Int."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","article-title":"Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease","volume":"13","author":"Stoeva","year":"2021","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib138","first-page":"46","article-title":"Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles","volume":"9","author":"Wu","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"7480","key":"10.1016\/j.semcancer.2025.07.005_bib139","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.semcancer.2025.07.005_bib140","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling","volume":"81","author":"Matsushita","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2025.07.005_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib142","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/biom14121646","article-title":"Lactate and lactylation: dual regulators of T-cell-mediated tumor immunity and immunotherapy","volume":"14","author":"Hao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2025.07.005_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101888","article-title":"Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation","volume":"81","author":"Trujillo","year":"2024","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib144","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: a key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113746","article-title":"Lactic acid induces transcriptional repression of macrophage inflammatory response via histone acetylation","volume":"43","author":"Shi","year":"2024","journal-title":"Cell Rep."},{"issue":"7779","key":"10.1016\/j.semcancer.2025.07.005_bib146","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib147","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00018-020-03645-1","article-title":"Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation","volume":"78","author":"Liu","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2025.07.005_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1283792","article-title":"Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2025.07.005_bib149","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/0008-5472.CAN-23-2521","article-title":"PABPC1L induces IDO1 to promote tryptophan metabolism and immune suppression in renal cell carcinoma","volume":"84","author":"Shu","year":"2024","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.semcancer.2025.07.005_bib150","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/1078-0432.CCR-18-0980","article-title":"Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy","volume":"24","author":"Orillion","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2025.07.005_bib151","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib152","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","article-title":"Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance","volume":"54","author":"Liang","year":"2022","journal-title":"Ann. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2025.07.005_bib153","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200673RRR","article-title":"Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor-promoted inflammatory responses and prostate cancer progression","volume":"36","author":"Zhao","year":"2022","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib154","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-021-00766-9","article-title":"NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Discov."},{"issue":"6649","key":"10.1016\/j.semcancer.2025.07.005_bib155","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2296","article-title":"A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers","volume":"380","author":"Fidelle","year":"2023","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib156","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","article-title":"Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients","volume":"78","author":"Derosa","year":"2020","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib157","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2020.07.011","article-title":"Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti-PD-1 immune checkpoint inhibitors","volume":"78","author":"Salgia","year":"2020","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib158","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.it.2022.03.007","article-title":"Immunotherapy response-associated Akkermansia: canary in a coal mine?","volume":"43","author":"Cascone","year":"2022","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib159","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-018-03900-x","article-title":"Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy","volume":"9","author":"Anker","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib160","first-page":"352","article-title":"Microbiota and the landscape of the prostate tumor microenvironment","volume":"11","author":"Gupta","year":"2023","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib161","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jmii.2022.12.009","article-title":"Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling","volume":"56","author":"Bui","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.semcancer.2025.07.005_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100822","article-title":"Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)","volume":"32","author":"Peiffer","year":"2022","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33696\/cancerimmunol.6.078","article-title":"The role of tumor and host microbiome on immunotherapy response in urologic cancers","volume":"6","author":"Pfail","year":"2024","journal-title":"J Cancer Immunol. (Wilmington)"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib164","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12866-024-03372-8","article-title":"Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000475138","article-title":"Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group","volume":"27","author":"Aso","year":"1995","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib166","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.eururo.2021.05.018","article-title":"Is there a detrimental effect of antibiotic therapy in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab?","volume":"80","author":"Pederzoli","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib167","article-title":"Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib168","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/bju.16121","article-title":"The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials","volume":"133","author":"Robesti","year":"2024","journal-title":"BJU Int."},{"key":"10.1016\/j.semcancer.2025.07.005_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102787","article-title":"The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"129","author":"Zhang","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70050","article-title":"Role of Microbiota-derived Metabolites In Prostate Cancer Inflammation And Progression","volume":"43","author":"Kumar","year":"2025","journal-title":"Cell Biochem. Funct."},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib171","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","article-title":"The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC","volume":"14","author":"Jin","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib172","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/cdn\/nzac068.015","article-title":"Bifidobacterium longum RAPO ameliorates anti-tumor efficacy and immune-related adverse events of anti-PD-1 therapy in a mouse model of triple-negative breast cancer","volume":"6","author":"Kim","year":"2022","journal-title":"Curr. Dev. Nutr."},{"issue":"700","key":"10.1016\/j.semcancer.2025.07.005_bib173","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib174","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12888-025-06635-4","article-title":"The mediating effects of coping strategies between symptom clusters and quality of life in lung cancer patients undergoing immunotherapy","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.semcancer.2025.07.005_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107269","article-title":"Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial","volume":"164","author":"Lin","year":"2025","journal-title":"Oral. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib176","doi-asserted-by":"crossref","first-page":"335","DOI":"10.59249\/CPTG1770","article-title":"The power of thought: the role of psychological attentiveness and emotional support in patient trajectories","volume":"97","author":"Prabakar","year":"2024","journal-title":"Yale J. Biol. Med."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib177","first-page":"724","article-title":"Exercise and the gut microbiome: implications for supportive care in cancer","volume":"31","author":"Hart","year":"2023","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib178","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/nu17020335","article-title":"The Role of maintaining nutritional adequacy status and physical activity in onco-nephrology: not a myth anymore, but a reality","volume":"17","author":"Trevisani","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.semcancer.2025.07.005_bib179","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jshs.2018.09.009","article-title":"The compelling link between physical activity and the body's defense system","volume":"8","author":"Nieman","year":"2019","journal-title":"J. Sport Health Sci."},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.trecan.2021.02.005","article-title":"Targeting the gut microbiome to mitigate immunotherapy-induced colitis in cancer","volume":"7","author":"Chang","year":"2021","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib181","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5217\/ir.2023.00019","article-title":"Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review","volume":"21","author":"Hwang","year":"2023","journal-title":"Intest Res."},{"key":"10.1016\/j.semcancer.2025.07.005_bib182","article-title":"Interaction between gut microbiota and immune checkpoint inhibitor-related colitis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib183","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","article-title":"Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib184","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus calmette-guerin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur. Urol."},{"issue":"6529","key":"10.1016\/j.semcancer.2025.07.005_bib185","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.semcancer.2025.07.005_bib186","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","article-title":"Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor","volume":"32","author":"Kim","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.semcancer.2025.07.005_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.2320","article-title":"LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: preliminary results of the randomized phase II TACITO trial","volume":"35","author":"Ciccarese","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib188","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ibd\/izy019.043","article-title":"P038 fecal microbiota transplant (FMT) for immuno-checkpoint inhibitor-induced colitis (ICI-C) in a 50 year old female with bladder cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib189","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00262-022-03329-8","article-title":"Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma","volume":"72","author":"Ninkov","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-kappaB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib191","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/s41467-020-18649-5","article-title":"Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients","volume":"11","author":"Daisley","year":"2020","journal-title":"Nat. Commun."},{"issue":"6575","key":"10.1016\/j.semcancer.2025.07.005_bib192","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib193","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2025.102306","article-title":"Nonintravesical interventions for preventing intravesical recurrence in patients with nonmuscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"23","author":"Tsuboi","year":"2025","journal-title":"Clin. Genitourin. Cancer"},{"issue":"23","key":"10.1016\/j.semcancer.2025.07.005_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235551","article-title":"Bladder cancer and probiotics: what do we know so far?","volume":"15","author":"Sanchez-Pellicer","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2025.07.005_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624434","article-title":"Enhancing checkpoint inhibitor therapy in solid tissue cancers: the role of diet, the microbiome & microbiome-derived metabolites","volume":"12","author":"Malczewski","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2025.07.005_bib197","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.cmet.2024.10.019","article-title":"Dual impacts of serine\/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation","volume":"36","author":"Tong","year":"2024","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib198","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-024-06641-6","article-title":"Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review","volume":"15","author":"Golonko","year":"2024","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib199","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","article-title":"Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy","volume":"160","author":"Matson","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2025.07.005_bib200","article-title":"Engineered bacteria: strategies and applications in cancer immunotherapy","author":"Zhang","year":"2024","journal-title":"Fundam. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2025.07.005_bib201","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41423-024-01153-x","article-title":"Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy","volume":"21","author":"Zhu","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcancer.2025.07.005_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.009","article-title":"Advances in bacterial cancer therapies using synthetic biology","volume":"5","author":"Chien","year":"2017","journal-title":"Curr. Opin. Syst. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib203","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2025.07.005_bib204","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","author":"Jian","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.semcancer.2025.07.005_bib205","article-title":"Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy","author":"Rouanne","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib206","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12032-024-02578-0","article-title":"Salmonella-based therapeutic strategies: improving tumor microenvironment and bringing new hope for cancer immunotherapy","volume":"42","author":"He","year":"2024","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib207","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2298444","article-title":"Salmonella immunotherapy engineered with highly efficient tumor antigen coating establishes antigen-specific CD8+ T cell immunity and increases in antitumor efficacy with type I interferon combination therapy","volume":"13","author":"Wang","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2025.07.005_bib208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2019.10.033","article-title":"Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium","volume":"469","author":"Guo","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib209","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40816-017-0045-8","article-title":"How the microbiome is influenced by the therapy of urological diseases: standard versus alternative approaches","volume":"3","author":"Naber","year":"2017","journal-title":"Clin. Phytosci."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib210","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1038\/s41467-022-31654-0","article-title":"A metagenomic DNA sequencing assay that is robust against environmental DNA contamination","volume":"13","author":"Mzava","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib211","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1038\/s41467-023-40137-9","article-title":"Droplet-based high-throughput single microbe RNA sequencing by smRandom-seq","volume":"14","author":"Xu","year":"2023","journal-title":"Nat. Commun."},{"issue":"6597","key":"10.1016\/j.semcancer.2025.07.005_bib212","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm1483","article-title":"High-throughput, single-microbe genomics with strain resolution, applied to a human gut microbiome","volume":"376","author":"Zheng","year":"2022","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.semcancer.2025.07.005_bib213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00203-023-03589-7","article-title":"It's all relative: analyzing microbiome compositions, its significance, pathogenesis and microbiota derived biofilms: challenges and opportunities for disease intervention","volume":"205","author":"Zaidi","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib214","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41588-021-00991-z","article-title":"Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort","volume":"54","author":"Qin","year":"2022","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.21873\/cdp.10354","article-title":"Prognostic impact of the administration of antibiotics and proton pump inhibitors in immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma","volume":"4","author":"Katsurayama","year":"2024","journal-title":"Cancer Diagn. Progn."},{"issue":"7659","key":"10.1016\/j.semcancer.2025.07.005_bib216","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature22972","article-title":"Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist","volume":"546","author":"Spaulding","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib217","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40005-016-0259-7","article-title":"Probiotic delivery systems: a brief overview","volume":"46","author":"Kim","year":"2016","journal-title":"J. Pharm. Investig."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib218","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semcancer.2025.07.005_bib219","doi-asserted-by":"crossref","DOI":"10.1128\/aem.01665-23","article-title":"Use of CRISPR interference for efficient and rapid gene inactivation in Fusobacterium nucleatum","volume":"90","author":"Zhou","year":"2024","journal-title":"Appl. Environ. Microbiol"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cels.2018.06.008","article-title":"Synthetic biology and engineered live biotherapeutics: toward increasing system complexity","volume":"7","author":"Ozdemir","year":"2018","journal-title":"Cell Syst."},{"issue":"20","key":"10.1016\/j.semcancer.2025.07.005_bib221","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1021\/acsnano.4c00830","article-title":"Polyphenolic nanoparticle-modified probiotics for microenvironment remodeling and targeted therapy of inflammatory bowel disease","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib222","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"issue":"4","key":"10.1016\/j.semcancer.2025.07.005_bib223","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043232","article-title":"Microfluidic organ-on-a-chip: a guide to biomaterial choice and fabrication","volume":"24","author":"Cao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2025.07.005_bib224","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cobeha.2019.01.011","article-title":"Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition","volume":"28","author":"Madison","year":"2019","journal-title":"Curr. Opin. Behav. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2025.07.005_bib225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-025-02159-1","article-title":"Gut dysbiosis conveys psychological stress to activate LRP5\/beta-catenin pathway promoting cancer stemness","volume":"10","author":"Cui","year":"2025","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:09:34Z","timestamp":1772780974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X25000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":225,"alternative-id":["S1044579X25000987"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.07.005","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-microbiota interactions in genitourinary cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}